– Global Power Synergy (GPSC) invests 14.8 billion baht to acquire 41.6% of a 3,744MW Avaada solar plant in India. The transaction enhances GPSC’s renewable energy portfolio in line with the group’s renewable energy target of 8,000 megawatts in 2030. GPSC aims to acquire a further 200-300 MW of wind turbines in Taiwan by the end of this year, according to the news. Analysts have given a “BUY” recommendation with a target price of 112 baht (upside 42%).
– Tisco Financial Group (TISCO) to announce the financial statement half year 2021 today (July 15). Analysts predict 2Q21 earnings of 1.73 billion baht, up 30%, on the back of a surge in fee income and a reduction in provisioning. As a result, the coverage ratio remained high at 222% to cushion against any potential risks due to the new Covid-19 spread. Analysts have given a “BUY” recommendation with a target price of 108 baht.
– Asia Plus Securities (ASPS) believes that with Thailand’s cabinet approval of new Covid-19 relief measures, this issue will boost retail plays, i.e. DOHOME, COM7, and SPVI. While CRC, ILM, and COM7 will gain from temporary store closures and cost-cutting measures. Meanwhile, the Food and Drug Administration (FDA) has approved Covid-19 antigen test kits for over-the-counter sale. Analysts see positive towards stocks in the medical devices and equipment sector.
– Analysts forecast COM7‘s earnings to reach 456 million baht in 2Q21, a 66.2% gain, owing to increased revenue from sales on the back of strong demand for IT products, notably work-from-home items, in the aftermath of a serious Covid-19 epidemic. As a result, net profit could increase by 81.7% to 1,022 million baht in the first half of 2021. Analysts have given a “BUY” recommendation with a target price of 77 baht.
– Thonburi Healthcare Group (THG) chairman Boon Vanasin, “Dr. Boon”, said he welcomed the Government Pharmaceutical Organization (GPO)’s accusation of him providing false information after he revealed the procurement of Moderna Covid-19 vaccines. Meanwhile, turbulence arose in Nonthaburi following the local authority’s decision to suspend use of the AstraZeneca vaccine as a first dose in favor of Sinovac.